Novavax to Participate in Jefferies London Healthcare Conference

PR Newswire

GAITHERSBURG, Md., Nov. 11, 2026

GAITHERSBURG, Md., Nov. 11, 2026 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX) today announced that company management will participate in the following upcoming investor conference:

  • Jefferies London Healthcare Conference, London, United Kingdom
    Fireside chat on Tuesday, November 17, 2026, at 5:00 p.m. GMT

A live webcast of the fireside chat will be available on the “Events & Presentations” page of the Company’s website at ir.novavax.com. A replay of each webcast will be available for 30 days following the presentation.

About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world’s most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M® adjuvant and protein-based nanoparticles. The Company’s corporate growth strategy is designed to deliver value via three key strategic pillars: partnering its technology, capital-efficient research and development (R&D) innovation and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid™, R21/Matrix-M™), Matrix technology and research and development assets. Please visit novavax.com and LinkedIn for more information. 

Contacts:

Investors
Naina Zaman 
240-410-5353  
ir@novavax.com 

Media 
Yvonne Sprow 
240-720-7804  
media@novavax.com 

Novavax Logo

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-jefferies-london-healthcare-conference-302936885.html

SOURCE Novavax, Inc.

About The Author
Novavax, Inc.